Gérard Zalcman
Centre de Recherche Institut Curie
421 papers found
Refreshing results…
BioCAST/IFCT-1002: epidemiological and molecular features of lung cancer in never-smokers
UploadActivity of Crizotinib in MET Amplified NSCLC: Preliminary Results of the AcSe Trial
UploadCrizotinib Outcome and Post-Progression Management in ALK plus NSCLC: IFCT-1302 CLINALK
UploadCrizotinib in Patients with ROS1 NSCLC. Preliminary Results of the AcSe Trial
UploadFirst-Line Crizotinib versus Chemotherapy in ALK-Positive Lung Cancer (vol 371, pg 2167, 2014)
UploadFirst-line crizotinib versus chemotherapy in ALK-positive lung cancer.
Download from orbi.ulg.ac.beMissing publications? Search for publications with a matching author name.